Scalper1 News
Pfizer (PFE) sweetened its bid for AstraZeneca (AZN) to about 63.1 billion pounds ($106.5 billion), aiming to bring the U.K.’s second-biggest drugmaker to the negotiating table. The offer values AstraZeneca at 50 pounds a share ($84.47) in cash and stock, New York-based Pfizer said in statement today. The London-based company rejected a proposal of 46.61 pounds a share, announced April 28. Pfizer is raising its bid after Chief Scalper1 News
Scalper1 News